Therapy of relapsed/refractory multiple myeloma with a combination of Lenalidomide plus Dexamethasone: First interim analysis of the non-interventional study "Revlimid"

被引:0
|
作者
Knauf, W. [1 ]
Aldaoud, A. [2 ]
Groschek, M. [3 ]
Teichmann, B. [4 ]
Harde, J. [4 ]
Hasskarl, J. [4 ]
机构
[1] Onkol Gemeinschaftspraxis, Frankfurt, Germany
[2] Dr Aldaoud Dr Schwarzer Forsch Gesell mbH, Leipzig, Germany
[3] Onkol Gemeinschaftspraxis, Wurselen, Germany
[4] iOMEDICO AG, Freiburg, Germany
来源
ONKOLOGIE | 2013年 / 36卷
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:154 / 155
页数:2
相关论文
共 50 条
  • [1] Revlimid-NIS: Non-interventional study on therapy of relapsed/refractory multiple myeloma with a combination of lenalidomide plus dexamethasone
    Knauf, W.
    Aldaoud, A.
    Maintz, C.
    Groschek, M.
    Teichmann, B.
    Harde, J.
    Trarbach, T.
    [J]. Oncology Research and Treatment, 2015, 38 : 238 - 238
  • [2] Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
    Dimopoulos, Meletios
    Spencer, Andrew
    Attal, Michael
    Prince, H. Miles
    Harousseau, Jean-Luc
    Dmoszynska, Anna
    San Miguel, Jesus
    Hellmann, Andrzej
    Facon, Thierry
    Foa, Robin
    Corso, Alessandro
    Masliak, Zvenyslava
    Olesnyckyj, Marta
    Yu, Zhinuan
    Patin, John
    Zeldis, Jerome B.
    Knight, Robert D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21): : 2123 - 2132
  • [3] Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma
    Dabkara, Deepak
    Bajpai, Jyoti
    [J]. INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2008, 29 (03) : 10 - 13
  • [4] Lenalidomide plus dexamethasone for patients with relapsed or refractory multiple myeloma: Final results of a non-interventional study and comparison with the pivotal phase 3 clinical trials
    Knauf, Wolfgang
    Aldaoud, Ali
    Losem, Christoph
    Mittermueller, Johann
    Neise, Michael
    Niemeier, Beate
    Harde, Johanna
    Trarbach, Tanja
    Potthoff, Karin
    [J]. LEUKEMIA RESEARCH, 2018, 68 : 90 - 97
  • [5] Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma
    Palumbo, Antonio
    Dimopoulos, Meletios
    San Miguel, Jesus
    Harousseau, Jean-Luc
    Attal, Michel
    Hussein, Mohamad
    Knop, Stefan
    Ludwig, Heinz
    von Lilienfeld-Toal, Marie
    Sonneveld, Pieter
    [J]. BLOOD REVIEWS, 2009, 23 (02) : 87 - 93
  • [6] Lenalidomide (Revlimid), bortezomib (Velcade) and dexamethasone for heavily pretreated relapsed or refractory multiple myeloma
    Jimenez-Zepeda, Victor H.
    Reece, Donna E.
    Trudel, Suzanne
    Chen, Christine
    Tiedemann, Rodger
    Kukreti, Vishal
    [J]. LEUKEMIA & LYMPHOMA, 2013, 54 (03) : 555 - 560
  • [7] Daratumumab plus lenalidomide and dexamethasone versus lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX
    Dimopoulos, Meletios A.
    San-Miguel, Jesus
    Belch, Andrew
    White, Darrell
    Benboubker, Lotfi
    Cook, Gordon
    Leiba, Merav
    Morton, James
    Ho, P. Joy
    Kim, Kihyun
    Takezako, Naoki
    Moreau, Philippe
    Kaufman, Jonathan L.
    Sutherland, Heather J.
    Lalancette, Marc
    Magen, Hila
    Iida, Shinsuke
    Kim, Jin Seok
    Prince, H. Miles
    Cochrane, Tara
    Oriol, Albert
    Bahlis, Nizar J.
    Chari, Ajai
    O'Rourke, Lisa
    Wu, Kaida
    Schecter, Jordan M.
    Casneuf, Tineke
    Chiu, Christopher
    Soong, David
    Sasser, A. Kate
    Khokhar, Nushmia Z.
    Avet-Loiseau, Herve
    Usmani, Saad Z.
    [J]. HAEMATOLOGICA, 2018, 103 (12) : 2088 - 2096
  • [8] Lenalidomide (Revlimid), Bortezomib (Velcade) and Dexamethasone (RVD) for Heavily Pretreated Relapsed or Refractory Multiple Myeloma
    Jimenez-Zepeda, Victor H.
    Reece, Donna E.
    Trudel, Suzanne
    Chen, Christine
    Kukreti, Vishal
    [J]. BLOOD, 2011, 118 (21) : 1266 - 1267
  • [9] Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma
    Nikhil C Munshi
    Constantine Mitsiades
    Paul G Richardson
    Kenneth C Anderson
    [J]. Nature Clinical Practice Oncology, 2008, 5 : 374 - 375
  • [10] Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma
    Munshi, Nikhil C.
    Mitsiades, Constantine
    Richardson, Paul G.
    Anderson, Kenneth C.
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (07): : 374 - 375